Liebow, C., et al. "Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase." Proc. of the Nat. Acad. of Sciences of the USA, vol. 86, No. 6 (1989)pp. 2003-2007. |
Pinski, J., et al. "Inhibition of Growth of MKN45 Human Gastric-Carcinoma Xenografts in Nude Mice by Treatment with Bombesin/Gastrin-Releasing-Peptide Antagonist (RC-3095) and Somatostatin Analogue RC-160." International Journal of Cancer, vol. 57, No. 4 (1994) pp. 574-580. |
E. Bombardieri, et al., "Somatostatin Receptor Imaging of Small Cell Lung Cancer . . . Scintigraphy," European Journal of Cancer, vol. 31A, No. 2, pp.184-188, 1995. |
J. Pinski, et al., "Somatostatin Analogues And Bombesin/Gastrin . . . In Vitro And In Vivo," Peptide Analogues In Glioblastomas, vol. , pp.5895-5901, (1994). |
P.A. Bunn, Jr., et al., "Effects of Neuropeptide Analogues on . . . Cancer Cell Lines," Cancer Research 54, pp. 3602-3610, Jul. 1, 1994. |
G. Lilling, et al., "Inhibition of Human Neuroblastoma . . . VIP Antagonist," Journal of Molecular Neuroscience, vol. 5, 1994/1995, pp. 231-239. |
H. Reile, et al., "Characterization of High-Affinity Receptors for Bombesin/Gastrin Releasing . . . By Tumor Cells," The Prostate 25:29-38, (1994). |
I. Virgolini, M.D., et al., "Vasoactive Intestinal Peptide-Receptor . . . Endocrine Tumors," The New England Journal of Medicine, vol. 331, No. 17, pp. 1116-1121, Oct. 27, 1994. |
K. Frank-Raue, et al., "Somatostatin Receptor Imaging in Persistent Medullary Thyroid Carcinoma," Clinical Endocrinology (1995) 42, pp. 31-37. |
Gabor Halmos, et al., "Characterization of Bombesin/Gastrin-Releasing Peptide . . . Gastric Cancer," Cancer Letters 85 (1994), pp. 111-118. |
Antal Orosz, et al., "New Short-Chain Analogs of Substance-P . . . Cells In Vitro and In Vivo," Int. J. Cancer, 60, pp. 82-87, (1995). |
Karoly Szepeshazi, et al., "Combination of Nitrosamine-Induced . . . Bombesin/GRP Antagonist," Int'l. Journal of Pancreatology, vol. 16, Nos. 2-3, pp. 141-149, Oct.-Dec. 1994. |
P. Heinz-Erian, et al., "Characterization of a New Group of Substituted Substance P . . . Antagonists," Abstracts of Papers, pp. 1455, May 1986. |
Tim Mosmann, "Rapid Colorimetric Assay for Cellular Growth and . . . Cytotoxicity Assays," Journal of Immunological Methods, 65, (1983), pp. 55-63. |
I. Zachary, et al., "Bombesin, Vasopressin, and Endothelin Rapidly Stimulate . . . 3T3 Cells," Proc. Natl. Acad. Sci. USA, vol. 88, pp. 4577-4581, Jun. 1991. |
I. Gozes, et al., "Vasoactive Intestinal Peptide Potentiates Sexual Behavior . . . . Antagonist," Endocrinology, vol. 125, No. 6, pp. 2945-2949, 1989. |
P. Woll, et al., "[D-ARG.sup.1,D-PHE.sup.5,D-TRP.sup.7,9, LEU.sup.11 ] Substance P, A Potent Bombesin . . . In Vitro," Proc. Natl. Acad. Sci. USA, vol. 85, pp. 1859-1863, Mar. 1988. |
M. Jaggi, et al., "New, Sensitive and Specific Elisa for Detection . . . Supernatants," Journal of Immunoassay, 15(2), pp. 129-146 (1994). |
K. Gulya, et al., "Cyclic Somatostatin Octapeptide Analogues With High . . . Opioid Receptors," Life Sciences, vol. 38, No. 24, pp.2221-2229, 1986. |
M. Brown, et al., "Somatostatin: Analogs With Selected Biological Activities," Science, vol. 196, pp.1467-1469, (1977). |
J. T. Pelton, et al., "Design and Synthesis of Conformationally Constrained Somatostatin . . . Receptors," J. Med. Chem. 1986, 29, pp. 2370-2375. |
M. Jaggi, et al., "Establishment of Tumorigenic Cell Lines From Biopsies . . . Adenocarcinomas," Journal of Basic & Applied Biomedicine (1995) 3 (4), pp. 27-35. |
Frucht et al., Cancer Res., 52(5), 1114-22, 1992. |